Price T Rowe Associates Inc Relay Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$935 Billion
Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,137,681 shares of RLAY stock, worth $7.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,137,681

Previous 2,875,936 60.44%

Holding current value

$7.53 Million

Previous $9.95 Million 40.31%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$3.22 - $5.22 $5.6 Million - $9.07 Million	-1,738,255 Reduced 60.44%	1,137,681 $5.94 Million
Q2 2025 Aug 14, 2025	SELL	$2.0 - $3.49 $1.2 Million - $2.1 Million	-601,855 Reduced 17.31%	2,875,936 $9.95 Million
Q1 2025 May 14, 2025	BUY	$2.62 - $4.92 $408,851 - $767,766	156,050 Added 4.7%	3,477,791 $9.11 Million
Q4 2024 Feb 14, 2025	SELL	$4.12 - $6.8 $8.07 Million - $13.3 Million	-1,958,550 Reduced 37.09%	3,321,741 $13.7 Million
Q3 2024 Nov 14, 2024	BUY	$6.23 - $9.51 $1.5 Million - $2.29 Million	241,276 Added 4.79%	5,280,291 $37.4 Million

Q2 2024 Aug 14, 2024	SELL	$5.9 - $8.02 $10.9 Million - $14.8 Million	-1,840,582 Reduced 26.75%	5,039,015 $32.9 Million
Q1 2024 May 15, 2024	SELL	$7.5 - $12.07 $12.8 Million - $20.5 Million	-1,701,570 Reduced 19.83%	6,879,597 $57.1 Million
Q4 2023 Feb 14, 2024	SELL	$6.01 - $11.48 $166,951 - $318,902	-27,779 Reduced 0.32%	8,581,167 $94.5 Million
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $2.17 Million - $3.42 Million	263,429 Added 3.16%	8,608,946 $72.4 Million
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $14.8 Million - $27.1 Million	1,482,557 Added 21.6%	8,345,517 $105 Million
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $35.5 Million - $53.9 Million	2,369,956 Added 52.75%	6,862,960 $113 Million
Q4 2022 Feb 14, 2023	SELL	$14.16 - $24.02 $967,963 - $1.64 Million	-68,359 Reduced 1.5%	4,493,004 $67.1 Million
Q3 2022 Nov 14, 2022	SELL	$18.07 - $31.37 $13.4 Million - $23.2 Million	-738,944 Reduced 13.94%	4,561,363 $102 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $4 Million - $10.5 Million	300,589 Added 6.01%	5,300,307 $88.8 Million
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $17.1 Million - $27.3 Million	844,377 Added 20.32%	4,999,718 $150 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $66 Million - $94 Million	2,537,388 Added 156.83%	4,155,341 $128 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $13.2 Million - $16.9 Million	444,471 Added 37.88%	1,617,953 $51 Million
Q2 2021 Aug 16, 2021	SELL	$27.5 - $38.19 $9.12 Million - $12.7 Million	-331,610 Reduced 22.03%	1,173,482 $42.9 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $23.8 Million - $45 Million	731,517 Added 94.56%	1,505,092 $52 Million
Q4 2020 Feb 16, 2021	BUY	$35.51 - $54.03 $27.5 Million - $41.8 Million	773,575 New	773,575 $32.2 Million

Others Institutions Holding RLAY

# of Institutions

216

Shares Held

168M

Call Options Held

714K

Put Options Held

14.9K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $796M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Relay Therapeutics, Inc. Transaction History